HB Wealth Management LLC Acquires 513 Shares of Humana Inc. (NYSE:HUM)

HB Wealth Management LLC grew its position in Humana Inc. (NYSE:HUM – Free Report) by 15.8% during the 2nd quarter, Holdings Channel.com reports. The firm owned 3,756 shares of the insurance provider’s stock after purchasing an additional 513 shares during the period. HB Wealth Management LLC’s holdings in Humana were worth $1,403,000 as of its [...]

featured-image

HB Wealth Management LLC grew its position in Humana Inc. ( NYSE:HUM – Free Report ) by 15.8% during the 2nd quarter, Holdings Channel.

com reports. The firm owned 3,756 shares of the insurance provider’s stock after purchasing an additional 513 shares during the period. HB Wealth Management LLC’s holdings in Humana were worth $1,403,000 as of its most recent filing with the Securities and Exchange Commission.



A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC grew its holdings in shares of Humana by 32,648.4% during the 4th quarter.

International Assets Investment Management LLC now owns 134,596 shares of the insurance provider’s stock worth $61,619,000 after purchasing an additional 134,185 shares in the last quarter. Atria Wealth Solutions Inc. increased its holdings in Humana by 10.

8% in the fourth quarter. Atria Wealth Solutions Inc. now owns 3,157 shares of the insurance provider’s stock valued at $1,446,000 after purchasing an additional 307 shares during the period.

Kestra Private Wealth Services LLC increased its stake in shares of Humana by 9.3% in the fourth quarter. Kestra Private Wealth Services LLC now owns 1,883 shares of the insurance provider’s stock valued at $862,000 after buying an additional 160 shares during the period.

Auxano Advisors LLC acquired a new position in shares of Humana in the 4th quarter worth approximately $540,000. Finally, Brighton Jones LLC grew its holdings in Humana by 6.8% during the 4th quarter.

Brighton Jones LLC now owns 470 shares of the insurance provider’s stock worth $215,000 after acquiring an additional 30 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In HUM has been the topic of a number of recent analyst reports. Truist Financial boosted their price objective on Humana from $355.00 to $400.

00 and gave the company a “hold” rating in a research note on Monday, July 15th. Robert W. Baird started coverage on Humana in a research note on Thursday, May 30th.

They issued a “neutral” rating and a $374.00 price target on the stock. Oppenheimer raised their price objective on shares of Humana from $370.

00 to $400.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. Baird R W raised shares of Humana to a “hold” rating in a research note on Thursday, May 30th.

Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research note on Friday, August 2nd.

Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $396.

35. Humana Stock Down 0.3 % Shares of HUM opened at $351.

36 on Friday. The company has a market cap of $42.34 billion, a PE ratio of 21.

88, a P/E/G ratio of 2.09 and a beta of 0.51.

Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.

54. The business has a fifty day moving average of $367.81 and a 200 day moving average of $346.

62. The company has a quick ratio of 1.67, a current ratio of 1.

66 and a debt-to-equity ratio of 0.70. Humana ( NYSE:HUM – Get Free Report ) last released its earnings results on Wednesday, July 31st.

The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.

07. The business had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.

52 billion. Humana had a return on equity of 16.12% and a net margin of 1.

53%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year.

During the same period last year, the company earned $8.94 earnings per share. On average, sell-side analysts expect that Humana Inc.

will post 16.14 EPS for the current year. Humana Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th.

Stockholders of record on Monday, September 30th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Monday, September 30th.

This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.01%.

Humana’s dividend payout ratio is presently 22.04%. Humana Company Profile ( Free Report ) Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States.

It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. ( NYSE:HUM – Free Report ).

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter ..